Cancer cells more likely to genetically mutate
When cells become cancerous, they also become 100 times more likely to genetically mutate than regular cells, researchers have found. The findings may explain why cells in a tumor have so many genetic mutations, but could also be bad news for cancer treatments that target a particular gene controlling cancer malignancy.
The research was led by Dr. Lawrence Loeb, professor of pathology and biochemistry at the University of Washington School of Medicine in Seattle. Loeb will present his research Feb. 18 at the meeting of the American Association for the Advancement of Science in San Francisco.
Tailored diabetes care gets results
Culturally specific diabetes management programs work better than a one-size-fits-all approach, going by the results achieved with a program tailored to Latino patients.
“This diabetes management program works,” Dr. Todd Gilmer of the University of California at San Diego, the study’s lead author, told Reuters Health in an interview. “For the amount that this costs, you get valuable improvements in health.”
